Last updated on November 2019

Efficacy Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone


Brief description of study

The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone

Clinical Study Identifier: NCT03738215

Find a site near you

Start Over

Synergy Clinical Research

National City, CA United States
0.6miles
  Connect »